Real world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India - a multicentre chart review study (ROSELAND)
印度 ALK 重排晚期非小细胞肺癌患者二线及以上治疗中洛拉替尼的安全性和有效性真实世界研究 - 一项多中心图表回顾研究 (ROSELAND)
期刊:Ecancermedicalscience
影响因子:1.3
doi:10.3332/ecancer.2024.1667
Biswas, Bivas; Ghadyalpatil, Nikhil S; Patil, Shekar; Patel, Amol; Ganguly, Sandip; Rathore, Anvesh; Guleria, Bhupesh; Tarannum, Cpalli Firdouse; Ghosh, Joydeep; Kondapally, Mary Sravani; Thippeswamy, Ravi; Reddy, Shashidhara Haragadde Poppa; Roy, Somnath